@article {117536,
	title = {Prevention of hemoglobinopathies in Egypt.},
	journal = {Hemoglobin},
	volume = {33 Suppl 1},
	year = {2009},
	month = {2009},
	pages = {S14-20},
	abstract = {<p>The hemoglobin disorders are the most common clinically serious single gene disorders in the world. In Egypt, beta-thalassemia is the most common type with a carrier rate varying from 5.3 to \&gt; or =9\% and a gene frequency of 0.03. So, it was estimated that 1,000/1.5 million per year live births will suffer from thalassemia disease in Egypt (total live births 1,936,205 in 2006). beta-Thalassemia creates a social and financial burden for the patients{\textquoteright} family and the Egyptian government. The high frequency of beta-thalassemia carriers with increasing rate of newly born cases is a pressing reason for the importance to develop prevention program for beta-thalassemia in Egypt. Sickle-cell disease (SCD) is not frequent in Egypt except in the Oases where the carrier rate varies from 9 to 22\%. Our objectives were to provide an in-depth analysis of the current status of hemoglobinopathies in Egypt and what we need for prevention of these diseases.</p>
},
	keywords = {Anemia, Sickle Cell, Egypt, Genetic Counseling, Genetic Testing, Hemoglobinopathies, Heterozygote Detection, Humans, Premarital Examinations, Prenatal Diagnosis, Thalassemia},
	issn = {1532-432X},
	doi = {10.3109/03630260903346395},
	author = {Amal El-Beshlawy and Ilham Youssry}
}
